| Financial Year |
March 31 2023 |
| Monetary Funds |
981,762,562.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,554,000.00 |
| Accounts Receivable |
148,807,648.10 |
| Advances to Suppliers |
36,926,704.13 |
| Other Receivables |
27,448,876.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
468,006,333.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
566,572.42 |
| Total Current Assets |
1,668,072,697.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,500,419.25 |
| Investment Properties |
-- |
| Fixed Assetes |
458,028,508.76 |
| Under-construction Projects |
6,658,440.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,471,153.13 |
| R&D expenses |
-- |
| Goodwill |
24,461,889.99 |
| Long-Term Deferred and Prepaid Expenses |
10,104,437.97 |
| Deferred Income Tax Assets |
144,136.62 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
649,512,069.54 |
| Total Assets |
2,317,584,767.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
173,374,793.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,229,362.66 |
| Taxes Payable |
10,545,433.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,484,587.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,506,358.35 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
296,379,943.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,758,484.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,966,811.72 |
| Total Liabilities |
326,346,755.57 |
| Paid-In Capital(Or Share Stock) |
581,721,846.00 |
| Capital Surplus |
323,729,539.88 |
| Surplus Reserve |
195,514,424.74 |
| LESS:Treasury Stock |
26,482,970.61 |
| Undistributed Profits |
919,492,867.46 |
| Minority Stockholder's Interest |
-1,274,123.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,992,512,134.96 |
| Owner's Equity（Stockholder's Equity） |
1,991,238,011.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,317,584,767.18 |
